Keywords: r-pr, begins, rilutek, trial, parkinson, rhone-poulenc, rorer

R-PR Begins Rilutek Trial In Parkinson's

Article | 25 November 1998

Print This

Rhone-Poulenc Rorer is to start Phase III clinical trials using Rilutek(riluzole) tablets, a glutamate antagonist, in patients with recent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in